Health & Wellness · Head-to-head
Omron Platinum (BP5465) vs A&D Medical UA-651BLE
Which should you buy? Here's the honest call, pulled from our full The Best Home Blood Pressure Monitors of 2026 comparison.
The Omron Platinum (BP5465) pairs validated accuracy with automatic averaging, making its daily number the easiest to trust. The A&D Medical UA-651BLE delivers the same validated fundamentals for less, while the Withings suits sync-first users and wrist monitors are worth avoiding for routine use.
Omron Platinum (BP5465)
Buy itAutomatic three-reading averaging and validated accuracy make this the number you can trust with the least effort.
- TruRead averages three consecutive readings automatically
- IntelliSense AFib and irregular-heartbeat detection, with 200-reading, two-user memory
- Large desktop footprint
- Bluetooth app pairing occasionally needs a retry
A&D Medical UA-651BLE
Buy itA no-frills, twice-validated upper-arm monitor that nails the fundamental and skips the extras.
- Validated in more than one published clinical study
- Wide-range cuff and one-button operation with an irregular-heartbeat alert
- No on-device reading averaging
- Minimal on-unit memory, so history lives in the app
Side by side
| Omron Platinum (BP5465) | A&D Medical UA-651BLE | |
|---|---|---|
| Our verdict | Buy | Buy |
| Best for | Daily trackers and couples who want the most trustworthy reading with minimal effort. | Value-focused buyers who want validated accuracy without paying for features they will not use. |
| Price tier | $$$ · premium | $$ · mid-range |
The bottom line
Our overall pick is the Omron Platinum (BP5465) - Automatic three-reading averaging and validated accuracy make this the number you can trust with the least effort. Choose the A&D Medical UA-651BLE instead if value-focused buyers who want validated accuracy without paying for features they will not use.
Want the full picture, including the other options we compared and the popular one we'd skip? Read the complete The Best Home Blood Pressure Monitors of 2026.